Pharma Has High Hopes Of Pilot On Simultaneous Advice From EU Countries
Executive Summary
Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers.
You may also be interested in...
EU Countries Test Offering Simultaneous Scientific Advice
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.